What is AIMEDIS?
https://aim.aimedis.com/
AIMEDIS is a company on the frontier of e-health research and development, already operating
in more than 20 hospitals in 3 countries with more than 10,000 patients.
AIMEDIS is currently raising funds to develop version 2 of the AIMEDIS platform, using a dual
blockchain system for data immutability and ownership , even selling it! Our goal is to provide
patients ownership of their data while giving viewing capabilities for this data for any doctor they
choose. The future of healthcare is digital, and AIMEDIS is positioning itself as a trailblazer,
allowing AI, wearables and social media to work together for better health outcomes for all of its
patients.
AIMEDIS is a real company already working in more than 20 hospitals in 3 countries and already served over 10 000 patients.
Using the Aimedis platform, users can store, secure and share their medical information only with the people they want to share it with by using the Aimedis right management system.
Beside the records, AImedis offers videochat and communication with other patients and doctors, online prescriptions, online appointments, learning content, the inclusion of fitness trackers and devices like ECG or bloodpressure monitors into the system, while all transactions inside the system are backed by our porprietary AIMChain blockchain.
Aimedis is running in hospitals across Europe and Asia and is supporting scientific research to save lives.
What more aimed can do ?
- AIMEDIS is secured by two block-chains, private and public. They link with each-other in a immutable fashion
- AIMEDIS provides not only a Patient to Doctor network, but also a Patient for Patient Social Media Platform which -incentivizes contributions in form of AIM tokens
- AIMEDIS allows patients to have control over their data and even sell it
- AIMEDIS is lead by a team of word-class doctors and medical industry professionals
The token
The AIM token is used in several ways.
First, AIM holders will participate in the Aimedis health ecosystem and will be able to benefit from its applications and functionalities.
Second the pharmaceutical industry and scientific research facilities can pay patients a fee for participating in trials by granting access to dedicated areas of their medical records, which is 100% voluntary.
In the next step Aimedis will release AIMSocial, the platform that incentivises patients for helping and engaging with other patients.
Fair and incentivised support by patients for patients - worldwide.
Pre-sale here : https://aim.aimedis.com/
Token Summary
currency
Use of Revenue
57% Development
16% Operations
13% Marketing
8% Reserves
6% Legal
currency
AIM Token Allocations
50% ICO crowd sale
20% Community initiatives, marketing & legal
20% Team, supporters & advisory board
5% Legal reserve
5% Reserve
Decentralized and incentivized healthcare Revolutionary AI & a sophisticated dual blockchain model
A fully operational medical ecosystem
A cutting-edge social medical network
Videochat, medical records, trackers, appointments, prescriptions
eLearning, scientific research & professional medical IT
Aimedis is already revolutionizing healthcare and is live in hospitals across Europe and Asia.